The Common Toxicity Criteria (CTC) define adverse events following cancer therapy. It was designed for use in clinical trials of different therapeutic regimens.
Adverse events affecting lymphatics:
(1) lymphedema
(2) other defect
Adverse Event |
Finding |
Grade |
lymphedema |
none |
0 |
|
mild |
1 |
|
moderate, requires compression bandage; lymphocyst |
2 |
|
severe, limiting function; lymphocyst requiring surgery |
3 |
|
severe, limiting function and with ulceration |
4 |
other lymphatic defect |
none |
0 |
|
mild |
1 |
|
moderate |
2 |
|
severe |
3 |
|
life-threatening or disabling |
4 |
Specialty: Hematology Oncology, Cardiology